From government control to market-oriented pricing:new transformation of the pharmaceutical pricing mechanism

Wen CHEN
DOI: https://doi.org/10.13688/j.cnki.chr.2015.15158
2015-01-01
Abstract:TheOpinion on promoting pharmaceutical price reform issued by the National Development and Reform Commission and other six ministries points out the objective of gradually establishing a market-oriented pharmaceutical pricing mechanism to minimize direct government intervention on pharmaceutical prices. Mechanism transformation is the core of the pharmaceutical pricing reform. The governments,as market participants,will conduct the intervention through purchasing,payment and negotiation mechanisms and carry out comprehensive regulations through the regulations on medical and pricing behaviors to achieve the change from government control to market-oriented pricing. The effects of the change depend on the coordination of related policies of health insurance and health services.
What problem does this paper attempt to address?